What is Nutriband's earnings per share (EPS)?

Nutriband (NTRBW) reported diluted earnings per share of -$2.58 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Nutriband Financials

NTRBW

FY2026 annual

Revenue $2.0M -4.8% YoY

Net Income -$8.2M +21.5% YoY

EPS (Diluted) -$2.58 YoY not available

Free Cash Flow -$5.1M -8.9% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Apr 30, 2026 Reported Jun 11, 2026 Currency USD FYE January

Nutriband (NTRBW) reported $2.0M in revenue for fiscal year 2026, down 4.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NTRBW FY2026 2026-08-15

Nutriband’s financials show a capital-raising funded development model, with modest revenue far smaller than operating and research spend.

Across FY2025-FY2026, operating cash outflow totaled $9.8M, yet cash still ended FY2026 at $4.6M; that gap was bridged by financing inflows and a rising share count, which means the balance sheet is being replenished externally rather than by the underlying business. At the same time, gross margin fell to 27.8% while SG&A stayed multiple times larger than gross profit, so the main constraint is not manufacturing economics alone but the fixed cost base carried against a tiny revenue stream.

The company still looks like a development-stage operation: FY2026 revenue was only $2.0M, while R&D consumed nearly as much and total operating costs swamped gross profit, so reported losses mainly reflect spending scale that the current commercial base does not yet absorb.

Liquidity is currently cushioned — cash of $4.6M against current liabilities of $784K implies room to keep funding activity without near-term liquidity strain — but that cushion has come from capital raises, not from cash conversion, because free cash flow remained deeply negative in every reported year.

Financial Health Signals

Financial Health Score 50/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Nutriband's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Dilution

R&D Intensity

Revenue Progress

Burn Trend

Balance Sheet

Piotroski F-Score Partial

3/8

Nutriband passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

Nutriband reported a net loss of $8.2M while operations used $5.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Nutriband reported an operating loss of $8.3M against $23K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.0M

YoY-4.8%

5Y CAGR+16.6%

Nutriband generated $2.0M in revenue in fiscal year 2026. This represents a decrease of 4.8% from the prior year.

EBITDA

-$8.1M

YoY+18.8%

Nutriband's EBITDA was -$8.1M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 18.8% from the prior year.

Net Income

-$8.2M

YoY+21.5%

Nutriband reported -$8.2M in net income in fiscal year 2026. This represents an increase of 21.5% from the prior year.

EPS (Diluted)

-$2.58

Nutriband earned -$2.58 per diluted share (EPS) in fiscal year 2026.

Cash & Balance Sheet

Free Cash Flow

-$5.1M

YoY-8.9%

Nutriband recorded an outflow of $5.1M in free cash flow in fiscal year 2026, representing a cash shortfall after capex. This represents a decrease of 8.9% from the prior year.

Cash & Debt

$4.6M

YoY+6.1%

5Y CAGR+97.6%

Nutriband held $4.6M in cash as of fiscal year 2026; long-term debt is not reported for that period.

Shares Outstanding

12M

Nutriband had 12M shares outstanding in fiscal year 2026.

Dividends Per Share

Not reported for fiscal year 2026.

Margins & Returns

Gross Margin

27.8%

YoY-6.9pp

5Y CAGR-5.7pp

Nutriband's gross margin was 27.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 6.9 percentage points from the prior year.

Return on Equity

-123.2%

YoY+39.8pp

5Y CAGR-82.0pp

Nutriband's ROE was -123.2% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 39.8 percentage points from the prior year.

Operating Margin

Not shown for fiscal year 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending

$1.9M

YoY-39.4%

Nutriband invested $1.9M in research and development in fiscal year 2026. This represents a decrease of 39.4% from the prior year.

Capital Expenditures

$5K

YoY-94.2%

Nutriband invested $5K in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 94.2% from the prior year.

Share Buybacks

Not reported for fiscal year 2026.

NTRBW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

NTRBW quarterly income statement

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Revenue	$1.8M	$2.0M-4.8%	$2.1M+2.6%	$2.1M+0.3%	$2.1M+46.2%	$1.4M+50.7%	$944K+690.6%	$119K-51.3%	$245K	N/A	N/A
Cost of Revenue	$1.3M	$1.5M+5.3%	$1.4M-27.3%	$1.9M+7.5%	$1.8M+51.4%	$1.2M+88.0%	$627K+14.3%	$549K+90.5%	$288K	N/A	N/A
Gross Profit	$511K	$566K-23.8%	$743K-13.8%	$862K+14.9%	$750K+35.4%	$554K+75.3%	$316K+173.6%	-$430K-899.0%	-$43K	N/A	N/A
R&D Expenses	$1.5M	$1.9M-39.4%	$3.1M+59.1%	$2.0M+99.6%	$982K+138.8%	$411K	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$7.2M	$7.0M+62.1%	$4.3M+14.3%	$3.8M-3.6%	$3.9M-2.7%	$4.0M+38.1%	$2.9M+62.6%	$1.8M-45.5%	$3.3M+1812.4%	$172K+13.7%	$151K
Operating Income	-$8.2M	-$8.3M+19.1%	-$10.3M-111.1%	-$4.9M-8.9%	-$4.5M+26.8%	-$6.1M-135.4%	-$2.6M-31.8%	-$2.0M+40.9%	-$3.3M	N/A	-$151K
Interest Expense	$25K	$23K+5.3%	$21K-71.8%	$76K+814.6%	$8K-93.0%	$118K-57.8%	$281K+282.3%	$73K	N/A	N/A	N/A
Net Income	-$8.1M	-$8.2M+21.5%	-$10.5M-91.1%	-$5.5M-22.3%	-$4.5M+27.4%	-$6.2M-110.6%	-$2.9M-7.8%	-$2.7M+18.3%	-$3.3M	N/A	-$151K
EPS (Diluted)	-$2.58	-$2.58	-$0.99-43.5%	-$0.69-30.2%	-$0.53+33.8%	-$0.80	N/A	N/A	N/A	N/A	N/A

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Revenue	$433K+8.2%	$401K+15.8%	$346K-44.4%	$622K-6.7%	$667K+3.9%	$642K-0.5%	$646K+45.8%	$443K
Cost of Revenue	$237K-24.1%	$312K+12.3%	$278K-40.4%	$466K+12.1%	$415K+16.6%	$356K-21.6%	$455K+33.3%	$341K
Gross Profit	$197K+121.3%	$89K+29.8%	$69K-56.3%	$157K-37.7%	$252K-11.9%	$286K+49.7%	$191K+88.1%	$102K
R&D Expenses	$247K+31.5%	$188K-58.9%	$457K-18.7%	$563K-17.7%	$683K+39.5%	$490K-44.4%	$881K+13.8%	$774K
SG&A Expenses	$1.2M+30.6%	$922K-73.6%	$3.5M+118.6%	$1.6M+62.7%	$982K-44.2%	$1.8M+138.7%	$737K0.0%	$737K
Operating Income	-$1.3M-22.9%	-$1.0M+73.7%	-$3.9M-93.7%	-$2.0M-41.7%	-$1.4M+74.6%	-$5.6M-289.6%	-$1.4M-1.2%	-$1.4M
Interest Expense	$5K-42.2%	$9K+56.2%	$6K-3.9%	$6K+126.5%	$3K-73.9%	$10K+142.6%	$4K-19.7%	$5K
Net Income	-$1.2M-28.3%	-$968K+75.0%	-$3.9M-93.6%	-$2.0M-44.0%	-$1.4M+74.8%	-$5.5M-304.8%	-$1.4M+20.1%	-$1.7M
EPS (Diluted)	-$0.10	-$0.04	-$0.32	-$2.12	-$0.12+76.5%	-$0.51-325.0%	-$0.12+20.0%	-$0.15

Not reported in any period shown, so not listed: Income Tax.

NTRBW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

NTRBW quarterly balance sheet

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Total Assets	$7.5M+1.0%	$7.5M-0.6%	$7.5M-20.5%	$9.5M-25.8%	$12.7M+28.3%	$9.9M+351.7%	$2.2M-21.7%	$2.8M+1602.6%	$165K+337.1%	$38K
Current Assets	$5.0M+4.1%	$4.8M+369.2%	$1.0M-62.1%	$2.7M-50.7%	$5.5M+1639.5%	$314K+627.6%	$43K-92.7%	$590K+258.1%	$165K+337.1%	$38K
Cash & Equivalents	$4.6M+6.1%	$4.3M+774.7%	$493K-75.2%	$2.0M-59.4%	$4.9M+3118.5%	$152K+1392.9%	$10K-97.9%	$475K	N/A	$27K
Inventory	$118K-44.4%	$212K+25.8%	$169K-26.5%	$229K+74.2%	$132K+149.1%	$53K	N/A	N/A	$4K-48.6%	$8K
Accounts Receivable	$118K+60.3%	$74K-50.3%	$149K+31.5%	$113K+58.4%	$71K-34.7%	$109K+752.1%	$13K-1.9%	$13K	N/A	N/A
Goodwill	$1.7M0.0%	$1.7M-65.8%	$5.0M0.0%	$5.0M-6.1%	$5.3M-29.0%	$7.5M+338.0%	$1.7M0.0%	$1.7M	N/A	N/A
Total Liabilities	$868K-16.6%	$1.0M-3.5%	$1.1M+22.1%	$883K+0.3%	$880K-68.7%	$2.8M+39.2%	$2.0M+401.8%	$403K+828.8%	$43K+196.8%	$15K
Current Liabilities	$784K-20.2%	$983K-1.6%	$999K+33.5%	$749K-3.9%	$779K-69.7%	$2.6M+27.0%	$2.0M+401.8%	$403K+828.8%	$43K+196.8%	$15K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$2K+15.1%	$2K
Total Equity	$6.7M+3.9%	$6.4M-0.1%	$6.4M-24.9%	$8.6M-27.7%	$11.9M+66.8%	$7.1M+3953.9%	$175K-92.7%	$2.4M+1879.0%	$122K+425.8%	$23K
Retained Earnings	-$46.7M-21.4%	-$38.5M-37.5%	-$28.0M-24.4%	-$22.5M-24.9%	-$18.0M-52.2%	-$11.8M-32.9%	-$8.9M-44.0%	-$6.2M-116.9%	-$2.8M-1505.6%	-$177K

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Total Assets	$6.9M-8.7%	$7.5M-10.3%	$8.4M-17.3%	$10.2M+65.4%	$6.2M-17.6%	$7.5M-40.4%	$12.5M-8.0%	$13.6M
Current Assets	$4.4M-12.3%	$5.0M-14.2%	$5.8M-22.7%	$7.5M+119.3%	$3.4M-28.5%	$4.8M-22.6%	$6.2M-14.6%	$7.2M
Cash & Equivalents	$4.0M-12.4%	$4.6M-13.9%	$5.3M-24.1%	$7.0M+136.0%	$3.0M-31.3%	$4.3M-24.3%	$5.7M-15.7%	$6.8M
Inventory	$121K+3.0%	$118K-13.2%	$136K-1.5%	$138K-35.9%	$215K+1.5%	$212K+26.0%	$168K-24.8%	$224K
Accounts Receivable	$3K-97.8%	$118K-19.8%	$148K-8.2%	$161K+70.8%	$94K+27.5%	$74K-32.6%	$110K+61.2%	$68K
Goodwill	$1.7M0.0%	$1.7M0.0%	$1.7M0.0%	$1.7M0.0%	$1.7M0.0%	$1.7M-65.8%	$5.0M0.0%	$5.0M
Total Liabilities	$902K+3.9%	$868K-0.2%	$870K-48.3%	$1.7M+60.4%	$1.0M+0.7%	$1.0M-20.6%	$1.3M+11.8%	$1.2M
Current Liabilities	$832K+6.1%	$784K+1.5%	$773K-50.9%	$1.6M+69.9%	$925K-5.9%	$983K-21.2%	$1.2M+13.1%	$1.1M
Total Equity	$6.0M-10.3%	$6.7M-11.5%	$7.5M-11.1%	$8.5M+66.4%	$5.1M-20.6%	$6.4M-42.8%	$11.2M-9.9%	$12.5M
Retained Earnings	-$47.9M-2.7%	-$46.7M-2.1%	-$45.7M-9.3%	-$41.9M-5.0%	-$39.9M-3.6%	-$38.5M-16.7%	-$32.9M-4.3%	-$31.6M

Not reported in any period shown, so not listed: Long-Term Debt.

NTRBW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

NTRBW quarterly cash flow statement

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Operating Cash Flow	-$4.4M	-$5.1M-11.0%	-$4.6M-31.2%	-$3.5M-18.1%	-$3.0M-6.3%	-$2.8M-845.7%	-$297K+66.8%	-$894K+19.1%	-$1.1M-1090.5%	-$93K+37.2%	-$148K
Capital Expenditures	N/A	$5K-94.2%	$92K+77.8%	$52K-34.7%	$79K-2.8%	$82K	N/A	N/A	$4K	N/A	N/A
Free Cash Flow	N/A	-$5.1M-8.9%	-$4.7M-31.8%	-$3.6M-16.7%	-$3.1M-6.1%	-$2.9M	N/A	N/A	-$1.1M	N/A	N/A
Investing Cash Flow	N/A	-$5K+94.2%	-$92K-77.8%	-$52K+34.7%	-$79K+2.8%	-$82K-221.8%	$67K	N/A	-$404K	N/A	N/A
Financing Cash Flow	$5.4M	$5.4M-36.7%	$8.5M+309.1%	$2.1M+1203.6%	$160K-97.9%	$7.6M+1952.0%	$372K-13.6%	$430K-78.3%	$2.0M+2916.8%	$66K-62.4%	$175K

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Operating Cash Flow	-$563K+23.1%	-$732K+58.2%	-$1.8M-33.4%	-$1.3M+1.8%	-$1.3M-7.9%	-$1.2M-22.7%	-$1.0M+34.6%	-$1.5M
Capital Expenditures	N/A	$0	$0	$0-100.0%	$5K	$0-100.0%	$47K+20.7%	$39K
Free Cash Flow	N/A	-$732K+58.2%	-$1.8M-33.4%	-$1.3M+2.2%	-$1.3M-8.3%	-$1.2M-17.3%	-$1.1M+33.2%	-$1.6M
Investing Cash Flow	N/A	$0	$0	$0+100.0%	-$5K	$0+100.0%	-$47K-20.7%	-$39K
Financing Cash Flow	-$6K-1.4%	-$5K-107.9%	$70K-98.7%	$5.3M+100482.1%	-$5K+96.4%	-$147K-2744.9%	-$5K-0.8%	-$5K

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

NTRBW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

NTRBW quarterly financial ratios

Metric	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Gross Margin	27.8%-6.9pp	34.7%-6.6pp	41.3%+5.3pp	36.1%-2.9pp	39.0%+5.5pp	33.5%	-360.0%	-17.5%	N/A	N/A
Operating Margin	-408.4%	-480.7%	-233.6%	-215.2%	-429.7%	-275.1%	-1649.9%	-1358.1%	N/A	N/A
Net Margin	-404.1%	-489.9%	-263.0%	-215.6%	-434.3%	-310.8%	-2280.1%	-1358.1%	N/A	N/A
Return on Equity	-123.2%+39.8pp	-163.1%-77.9pp	-85.2%-32.9pp	-52.3%-0.2pp	-52.1%-10.8pp	-41.2%+1510.1pp	-1551.4%-1412.8pp	-138.5%	N/A	-654.5%
Return on Assets	-109.0%+31.3pp	-140.3%-67.4pp	-73.0%-25.6pp	-47.4%+1.1pp	-48.5%-18.9pp	-29.5%+94.3pp	-123.8%-5.2pp	-118.7%	N/A	-400.9%
Current Ratio	6.36+1.5x	4.88+3.9x	1.02-2.6x	3.60-3.4x	7.01+6.9x	0.12+0.1x	0.02-1.4x	1.47-2.3x	3.80+1.2x	2.58
Debt-to-Equity	0.130.0x	0.160.0x	0.17+0.1x	0.100.0x	0.07-0.3x	0.40-11.1x	11.53+11.4x	0.17+0.2x	0.01-0.1x	0.07
FCF Margin	-252.4%	-220.5%	-171.6%	-147.5%	-203.3%	N/A	N/A	-452.4%	N/A	N/A

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25
Gross Margin	45.4%+23.2pp	22.2%+2.4pp	19.8%-5.4pp	25.2%-12.6pp	37.8%-6.8pp	44.5%+14.9pp	29.6%+6.7pp	22.9%
Operating Margin	-289.4%	-254.8%	-1121.3%	-321.8%	-211.8%	-865.3%	-220.9%	-318.4%
Net Margin	-286.6%	-241.6%	-1119.0%	-321.4%	-208.1%	-858.8%	-211.0%	-385.1%
Return on Equity	-20.7%-6.2pp	-14.5%+36.8pp	-51.3%-27.8pp	-23.5%+3.7pp	-27.2%+58.6pp	-85.8%-73.7pp	-12.1%+1.6pp	-13.7%
Return on Assets	-18.0%-5.2pp	-12.8%+33.2pp	-46.0%-26.3pp	-19.7%+2.9pp	-22.6%+51.3pp	-73.9%-63.0pp	-10.9%+1.6pp	-12.5%
Current Ratio	5.26-1.1x	6.36-1.2x	7.53+2.7x	4.78+1.1x	3.71-1.2x	4.88-0.1x	4.96-1.6x	6.57
Debt-to-Equity	0.150.0x	0.130.0x	0.12-0.1x	0.200.0x	0.210.0x	0.160.0x	0.120.0x	0.09
FCF Margin	N/A	-182.6%	-506.4%	-211.0%	-201.1%	-192.9%	-163.6%	-357.4%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Aspire Biopharma Holdings Inc ASBPW

Geovax Labs Inc GOVXW

Lexaria Bioscien LEXXW

SAB BIOTHERAPEUTICS INC SABSW

TEVOGEN INC TVGNW

Where Nutriband Ranks

Frequently Asked Questions

What is Nutriband's annual revenue?

Nutriband (NTRBW) reported $2.0M in total revenue for fiscal year 2026. This represents a -4.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Nutriband's revenue growing?

Nutriband (NTRBW) revenue declined by 4.8% year-over-year, from $2.1M to $2.0M in fiscal year 2026.

Is Nutriband profitable?

No, Nutriband (NTRBW) reported a net income of -$8.2M in fiscal year 2026.

What is Nutriband's EBITDA?

Nutriband (NTRBW) had EBITDA of -$8.1M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

What is Nutriband's gross margin?

Nutriband (NTRBW) had a gross margin of 27.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Nutriband's return on equity (ROE)?

Nutriband (NTRBW) has a return on equity of -123.2% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Nutriband's free cash flow?

Nutriband (NTRBW) recorded an outflow of $5.1M in free cash flow during fiscal year 2026. This represents a -8.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Nutriband's operating cash flow?

Nutriband (NTRBW) recorded an outflow of $5.1M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

What are Nutriband's total assets?

Nutriband (NTRBW) had $7.5M in total assets as of fiscal year 2026, including both current and long-term assets.

What are Nutriband's capital expenditures?

Nutriband (NTRBW) invested $5K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Nutriband spend on research and development?

Nutriband (NTRBW) invested $1.9M in research and development during fiscal year 2026.

How many shares does Nutriband have outstanding?

Nutriband (NTRBW) had 12M shares outstanding as of fiscal year 2026.

What is Nutriband's current ratio?

Nutriband (NTRBW) had a current ratio of 6.36 as of fiscal year 2026, which is generally considered healthy.

What is Nutriband's debt-to-equity ratio?

Nutriband (NTRBW) had a debt-to-equity ratio of 0.13 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Nutriband's return on assets (ROA)?

Nutriband (NTRBW) had a return on assets of -109.0% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Nutriband's Piotroski F-Score?

Nutriband (NTRBW) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Nutriband's earnings high quality?

Nutriband (NTRBW) reported a net loss of $8.2M while operations used $5.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Nutriband cover its interest payments?

Nutriband (NTRBW) reported an operating loss of $8.3M against $23K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Nutriband?

Nutriband (NTRBW) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.